CT Angiography denials in California external review

In the California DMHC record, independent physician reviewers decided 26 published external-review cases involving CT Angiographyand overturned the plan’s denial in 23.1%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
26
2006–2021
Overturned
23.1%
6 denials reversed

By condition

Published outcomes when CT Angiography was denied for these conditions.
ConditionDecisionsOverturned
Coronary Artery Disease16
0%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
20
20%
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
6
33.3%
Typical time to a decision
21 days
Most land between 20 and 24 days
Handled as urgent
15.4%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested gastric emptying study, a computed tomography (CT) angiography and a fecal microbiota transplant for treatment of the enrollee, who has a history of abdominal pain. Findings: The physician reviewer found that the submitted documentation supports the medical necessity of a portion of the requested services. This patient has symptoms consistent with gastroparesis, but also consistent with other diseases.
Medical Necessity · 2016 · IMR MN16-23917
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for the computed tomography (CT) angiography (CPT 75574). Findings: The physician reviewer found that as noted by the American College of Cardiology Foundation (ACCF), coronary CTA with contrast is often used to evaluate possible anomalous coronary arteries. Studies found that “cardiac CTA provides excellent spatial and temporal resolution, allowing accurate anatomical assessment of these anomalies.” Moreover, if the contrast coronary CTA was not done, another study such as a cardiac catheterization would have been indicated. Given this support, the CTA (CPT 75574) performed was medically necessary for further evaluation of this patient’s medical condition.
Medical Necessity · 2018 · IMR MN18-27370

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Physician 1: The patient is a 57-year-old woman with hyperlipidemia and complaints of chest pain and shortness of breath. In November of 2000 she underwent a cardiac catheterization, which showed “Normal left ventrical function. No angiographic evidence for significant epicardial coronary artery disease. Small distal left anterior descending either normal variant and a small eddy, although cannot rule out diffuse concentric distal left anterior descending disease to account for the patient’s apical ischemia and atypical chest discomfort.” An adverse reaction to the catheter/anesthesia is not found in the dictated report.In March 2005 she underwent a stress myoview SPECT scan. She had no ischemia. The patient is unable to tolerate statins for hyperlipidemia. Per the submitted records, she is not on cardiac medications such as beta-blocker or nitrate.
Experimental/Investigational · 2006 · IMR EI06-5935
Physician 1: The patient is a 56-year-old woman who has a history of hyperlipidemia and smoking. She has been diagnosed with chest pain syndrome, she has “intermittent VEA” (ventricular ectopic activity) and she is treated with flecainide for “variable palpitations.” The specific arrhythmia that is being treated with flecainide was not described nor is the precise diagnosis associated with the palpitations. A stress test or perfusion study is not included in the documentation. The September 2006 provider’s note indicated the EKG was “NSR, NL” or normal. The provider also noted the patient did not have recurrent chest pain, but had intermittent VEA and chest pain with VEA. The provider indicated that CAD should be ruled out and referred the patient for CT angiography (CTA).
Experimental/Investigational · 2006 · IMR EI06-5964

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving CT Angiography, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied CT Angiography? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39